Health Creator

MADISON, Wis. (Business Wire EON/PRWEB ) July 31, 2008 — TomoTherapy Incorporated (NASDAQ: TOMO) announced today that it has extended its reach in Europe with the first TomoTherapy^® Hi∙Art^® treatment system set to be installed in Scandinavia, at Lund University Hospital in Sweden.

Jef Van Dam, general manager of TomoTherapy EMEA, said, “TomoTherapy is extremely pleased to partner with Lund University Hospital. This marks our entry into the Swedish market with a prestigious institution that pioneered the use of many technological advances in Scandinavia and Europe. We look forward to delivering the advanced Hi∙Art system to continue that tradition.”

Lund University Hospital conducted an extensive investigation of all commercially available intensity-modulated radiation therapy (IMRT) systems, including arc-based options on conventional platforms, before making the decision to purchase the TomoTherapy Hi∙Art system.

Charlott Wictor, strategic purchaser of medical equipment for the Skane region in Sweden, championed TomoTherapy and helped the purchase become reality: “This was a great team effort working with the Lund medical and physics experts to bring this advanced technology to our Swedish patients. TomoTherapy was clearly the best choice from both a high technology and economic standpoint.”

Jacob Engellau, M.D., Ph.D., head of radiation oncology at Lund University Hospital, believes TomoTherapy will have a great impact on patient treatments. “As a large center treating 2500 new patients yearly, we are dependent on high up-time and clinical reliability. The established and clinically well-implemented TomoTherapy Hi∙Art was the only system that could meet the demands of our clinic.”

Tommy Knöös, Ph.D., associate professor and head of radiation physics at Lund University Hospital, was also an important decision maker in the process. “We think TomoTherapy is the most advanced image-guided system for radiotherapy with an integrated functionality for imaging and localisation of the target volume. It also produces the most advantageous dose distributions for IMRT,” according to Knöös.

Added Engellau, “With the Hi∙Art system, we see obvious clinical advantages for treating complex radiation target volumes, multiple targets and targets requiring a high radiation dose with close proximity to healthy organs. Conventional 3D conformal radiation or IMRT can treat some but not all of these case types. If the cases can be attempted, we believe the results would be less conformal, less accurate and with much longer treatment times than with TomoTherapy.”

While TomoTherapy will be used to treat a wide array of cancers, the clinical experts at Lund plan to focus on anal, rectal, cervical, stomach and esophageal cancers. They will also be using the Hi∙Art system for stereotactic radiosurgery treatments and see greater possibilities for clinical trials involving simultaneously integrated boost (SIB) with or without dose escalation.

Lund University Hospital plans to install the TomoTherapy Hi∙Art system later this year.

About TomoTherapy Incorporated

TomoTherapy Incorporated has developed, markets and sells the TomoTherapy^® Hi·Art^® treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The Hi·Art treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company’s stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

Forward-Looking Statements

Statements in this release regarding future events, expectations and other similar matters, including but not limited to statements using the terms “look forward to” or “will” constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contained in this press release are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including but not limited to factors such as our ability to integrate acquired assets, ability to protect intellectual property, risks of interruption due to events beyond the company’s control, and the other risks listed from time to time in TomoTherapy’s filings with the U.S. Securities and Exchange Commission, which by this reference are incorporated herein. These forward-looking statements represent TomoTherapy’s judgments as of the date of this press release. TomoTherapy assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events or otherwise.

©2008 TomoTherapy Incorporated. All rights reserved. TomoTherapy, the TomoTherapy logo and Hi·Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated.

See Also:

• Backup Tapes and Drives Do Not Protect Critical Business Data or Applications From Floods, Hurricanes, Earthquakes, or Other Natural or Man-Made Disasters
• Flickr co-founder joins NYC start-up Hunch
• Yahoo shareholders meeting a case of deja vu?
• Freescale and Monebo Launch ECG-on-a-Chip Platform Solution to Aid Heart Monitoring : Advanced Hardware and Software Technology Designed to Enable More Efficient and Higher Quality Cardiac Care
• Sansa MP3 player smokes iPod nano for $39.99 shipped

[Via PRWeb: Medical Cancer]

MADISON, Wis. (Business Wire EON/PRWEB ) July 31, 2008 — TomoTherapy Incorporated (NASDAQ: TOMO) announced today that it has extended its reach in Europe with the first TomoTherapy^® Hi∙Art^® treatment system set to be installed in Scandinavia, at Lund University Hospital in Sweden.

Jef Van Dam, general manager of TomoTherapy EMEA, said, “TomoTherapy is extremely pleased to partner with Lund University Hospital. This marks our entry into the Swedish market with a prestigious institution that pioneered the use of many technological advances in Scandinavia and Europe. We look forward to delivering the advanced Hi∙Art system to continue that tradition.”

Lund University Hospital conducted an extensive investigation of all commercially available intensity-modulated radiation therapy (IMRT) systems, including arc-based options on conventional platforms, before making the decision to purchase the TomoTherapy Hi∙Art system.

Charlott Wictor, strategic purchaser of medical equipment for the Skane region in Sweden, championed TomoTherapy and helped the purchase become reality: “This was a great team effort working with the Lund medical and physics experts to bring this advanced technology to our Swedish patients. TomoTherapy was clearly the best choice from both a high technology and economic standpoint.”

Jacob Engellau, M.D., Ph.D., head of radiation oncology at Lund University Hospital, believes TomoTherapy will have a great impact on patient treatments. “As a large center treating 2500 new patients yearly, we are dependent on high up-time and clinical reliability. The established and clinically well-implemented TomoTherapy Hi∙Art was the only system that could meet the demands of our clinic.”

Tommy Knöös, Ph.D., associate professor and head of radiation physics at Lund University Hospital, was also an important decision maker in the process. “We think TomoTherapy is the most advanced image-guided system for radiotherapy with an integrated functionality for imaging and localisation of the target volume. It also produces the most advantageous dose distributions for IMRT,” according to Knöös.

Added Engellau, “With the Hi∙Art system, we see obvious clinical advantages for treating complex radiation target volumes, multiple targets and targets requiring a high radiation dose with close proximity to healthy organs. Conventional 3D conformal radiation or IMRT can treat some but not all of these case types. If the cases can be attempted, we believe the results would be less conformal, less accurate and with much longer treatment times than with TomoTherapy.”

While TomoTherapy will be used to treat a wide array of cancers, the clinical experts at Lund plan to focus on anal, rectal, cervical, stomach and esophageal cancers. They will also be using the Hi∙Art system for stereotactic radiosurgery treatments and see greater possibilities for clinical trials involving simultaneously integrated boost (SIB) with or without dose escalation.

Lund University Hospital plans to install the TomoTherapy Hi∙Art system later this year.

About TomoTherapy Incorporated

TomoTherapy Incorporated has developed, markets and sells the TomoTherapy^® Hi·Art^® treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The Hi·Art treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company’s stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

Forward-Looking Statements

Statements in this release regarding future events, expectations and other similar matters, including but not limited to statements using the terms “look forward to” or “will” constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contained in this press release are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including but not limited to factors such as our ability to integrate acquired assets, ability to protect intellectual property, risks of interruption due to events beyond the company’s control, and the other risks listed from time to time in TomoTherapy’s filings with the U.S. Securities and Exchange Commission, which by this reference are incorporated herein. These forward-looking statements represent TomoTherapy’s judgments as of the date of this press release. TomoTherapy assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events or otherwise.

©2008 TomoTherapy Incorporated. All rights reserved. TomoTherapy, the TomoTherapy logo and Hi·Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated.

See Also:

• Freescale and Monebo Launch ECG-on-a-Chip Platform Solution to Aid Heart Monitoring : Advanced Hardware and Software Technology Designed to Enable More Efficient and Higher Quality Cardiac Care
• 2008 Olympics: The digital games
• What to do when the executive has no clothes
• Speaker as Art: The Davone Rithm
• Surviving a week without micro-communicating

[Via PRWeb: Medical]

Connextions’ Technologies Help plans attract, retain and manage consumers.

Orlando, FL (Vocus/PRWEB ) July 31, 2008 — Gartner, Inc. has identified Connextions Inc. as a Marketing Applications vendor in its “Hype Cycle for Healthcare Payers, 2008″ report. Connextions, a business process outsourcing firm, helps health insurance plans to attract, retain and manage individual and small group members.

Since 1995, Gartner has used “Hype Cycles” as a representation of the maturity, adoption and business application of specific technologies. In her 2008 report, Gartner Researcher Vice President Joanne Galimi described marketing functions that “…enhance a healthcare insurer’s ability to segment, target and provide more-relevant content to frontline personnel, partners and customers.”

As employers continue to reduce or drop group health coverage of workers and as individuals bear greater responsibility for their wellness, health insurance companies are evolving from a wholesale B2B model to a retail B2C orientation.

Connextions’ marketing application strategies - based on a deep understanding of the healthcare industry and its work on behalf of several major U.S. health plans - deliver technology-based and human solutions necessary for plans to build an integrated approach to member acquisition, retention and service. Connextions’ broad range of consulting and business process outsourcing services increase revenue, decrease operating costs, enhance member persistency and strengthen brand loyalty.

In the Gartner report, Ms. Galimi wrote that health insurers’ “marketing strategies must evolve, and investments must shift toward measurable, highly addressable (knowledge about who the customer is) and highly aware campaigns (ability to be aware of responses) to improve response rates within a multichannel campaign management environment for the individual market.”

Ms. Galimi also notes, “Product changes…are costly, resource-consuming efforts for the IT and business areas of the health insurer. Therefore, health insurers must include a strategy for the acquisition of individual consumers (including new product development) into their business planning.”

In response to Connextions’ inclusion in the Gartner report, CEO Jack LeFort said, “We are currently helping several health plans incorporate a consumer-driven marketing model that will enable them to gain competitive advantage through speed to market, lower cost of acquisition and higher member retention. Our strategies are producing industry-leading results and differentiating health plans among all demographics of consumers in the marketplace.”

Connextions Inc. is a technology-based business process outsourcing firm with broad expertise in the healthcare industry, assisting well-known health insurance plans and healthcare providers in their efforts to attract, transact with, and retain members. Connextions is a privately held company, and part of the New Mountain Partners II, L.P. portfolio, a private equity fund sponsored and managed by Manhattan-based New Mountain Capital LLC.

About Connextions Inc.:
Founded in 1992, Connextions’ more than 2,500 professionals provide technology-based business solutions for a long list of America’s best-known corporate and healthcare organizations, including FedEx, Sprint, Mercedes-Benz, Olympus, SanDisk, Kaiser-Permanente, Colonial Penn, Caremark and Aetna. See www.connextions.com.

About New Mountain Capital:
New Mountain Capital, LLC is a New York-based private equity firm investing for long-term capital appreciation through direct investment in growth equity transactions, leveraged acquisitions and management buyouts. New Mountain seeks out the highest quality growth leaders in carefully selected industry sectors, and then works intensively with management to build the value of those companies. See www.newmountaincapital.com.

For additional information:
Gordon G. Andrew
Senior Vice President
Connextions, Inc.
(407) 563-4440
Cell: (609) 987-0200
gandrew @ connextions.com

See Also:

• Motivational CDs Increase Employee & Team Productivity During Tough Economic Times
• Extraordinary Breath - Making the Power of Deep Breathing Work For You
• Retirement Planning to Get Easier: The Next Paths Workshop Announced
• Institute for Financial Literacy Announces Keynote Speaker for 2008 Annual Conference on Financial Education: Deputy Assistant Secretary of the Treasury Dan Iannicola
• Premier Club Praises the Work of the Charity Children with Leukaemia.

[Via PRWeb: Medical]

Third Brigade best-of-breed security deployment helps protect Verispan’s HIPAA-compliant, de-identified, patient-centric market research data used by top 50 pharmaceutical companies

Reston, VA and Ottawa, ON (PRWEB) July 31, 2008 — Third Brigade, a security software company specializing in host intrusion defense, today announced that Verispan, the nation’s leading provider of HIPAA-compliant, de-identified, patient-centric prescription data, has implemented the Third Brigade host intrusion detection and prevention system (IDS/IPS). The system adds another level of security to Verispan’s comprehensive, defense-in-depth security initiatives.

An ongoing awareness of increased online threats led Verispan to test, purchase and deploy Third Brigade Deep Security. “Third Brigade adds further layers of protection to our Network Security posture that helps us continue to meet and exceed our clients’ security requirements,” said Erik Sciortino, Associate Director of Network Operations for Verispan.

Mr. Sciortino highlighted performance, manageability and easy integration into Verispan’s existing security environment as key advantages of the Third Brigade host intrusion detection and prevention system. Verispan uses Third Brigade’s management tools, recommendation scanning and automatic update capabilities to maintain optimum protection for Verispan servers.

“Verispan is yet another example of a leading service organization recognizing the value of Third Brigade host intrusion defense for their defense-in-depth strategy,” said Wael Mohamed, President and CEO, Third Brigade. “HIPS is now being added to the service customer’s checklist, and we are repeatedly being selected to help the service providers deliver.”

Verispan is the leading provider of de-identified, patient-centric longitudinal data delivered in near real time, as well as one of the major providers of healthcare information and services overall. It presents clients with a broad-based service company to meet the vast majority of information and analysis needs. Verispan’s clients include virtually all of the top 50 pharmaceutical companies (market research, managed care, marketing/brand management, sales analytics, sales operations and other functions), most of the leading biotech and medical/surgical companies, the Food and Drug Administration (to track de-identified patient-centric utilization across the industry), Wall Street, consulting firms and other healthcare-related organizations. Headquartered in Yardley, Pa., Verispan employs over 500 dedicated healthcare information professionals. The company’s Web site is www.verispan.com.

About Third Brigade
Third Brigade (www.thirdbrigade.com) best-of-breed host intrusion defense systems protect critical data and applications, including those on virtual machines, from attacks that bypass or penetrate network defenses, and target vulnerabilities in operating systems, and enterprise and web applications. With a high performance deep packet inspection engine, Third Brigade Deep Security detects and prevents known and zero-day attacks, and provides a virtual patch for Microsoft® Windows®, Solaris™, Linux, and other Unix® hosts on physical and virtualized systems. It helps ensure regulatory compliance with PCI and other standards, and prevents costly business disruptions. Unlike others, Third Brigade provides broader, faster and simpler protection. Third Brigade. That’s control.

Note: “Third Brigade”, “Deep Security Solutions”, and the Third Brigade logo are trademarks of Third Brigade, Inc. and may be registered in certain jurisdictions. All other company and product names are trademarks or registered trademarks of their respective owners.

For more information:
Laura Maio
Media & Analyst Relations
Third Brigade, Inc.
(T) 613-599-4505 x2238
(M) 613-219-2800

See Also:

• Can you ‘report freely’ with some Olympic internet restrictions?
• Two Cambridge Boutiques Move to Harvard Square
• American Kidney Fund Launches Screening Program in New York City
• No More Jalapenos? No Problemo! Salmonella-Free Alternatives : No More Jalapenos? No Problemo, yes Poblano!
• On-X Life Technologies Significantly Reduces Study Management Costs with TEMPO from Clinipace

[Via PRWeb: Medical]

SafeEvault launches upgraded versions of its Remote Online Data Backup Solutions and Virtual Business Continuity Network plans. These fully automated remote data and application protection solutions safeguard small to mid-sized businesses from disasters which often cripple physical backup devices.

Dallas, TX (PRWEB) July 31, 2008 — Market research firm Gartner says that less than 1% of small businesses perform daily backups. During the recent floods in the Midwest and fires in the West, many businesses suffered potentially door closing data losses from destroyed or missing backup devices.

SafeEvault

Many of these businesses relied exclusively on tape drives or other hardware based solutions which left them at a high risk of losing all their mission critical data and applications.

According to Pricewaterhouse Coopers, 7 out of 10 small firms shut their doors within a year if they experience a major data loss that cannot be recovered. There is no reason for businesses to put themselves in this situation.

Business data and critical applications can be protected from almost any type of disaster by using the fastest growing data protection solutions on the market today — Remote Online Data Backup and Virtual Application Server Replication. Several IT service providers offer services for backing up business critical data, and a few also provide application server restoration, via the internet, at very affordable prices.

Too many small to mid-sized businesses lost business critical data and application servers in recent disasters. Online data protection solutions would have allowed most of these companies to gain access to their data and server applications immediately via the internet. Companies can be back in business within hours, not weeks, just by logging onto any computer with internet access.

XYZ Company sustains a flood and loses its critical data and the use of its application servers. Online solutions allow access to their business applications by using a virtual desktop accessed by a secure web portal. The user backs up critical data into a virtual business continuity network housing their applications and in a few hours XYZ Company is back in business.

Most online service providers offer a free trial period. Owners or IT managers shouldn’t wait until disaster strikes and it’s too late to save their business. Utilizing a free evaluation period is the best way for a business to see how easy and inexpensive it is to protect their most valuable asset — their data and mission critical applications.

About SafeEvault:
Our nearly two decades as an information technology service provider, and the new VBCN technology, sets us apart from other online backup service providers. Years of extensive calibration of sophisticated software, investment in the most advanced network devices and the latest security technologies, makes SafeEvault the leader in business continuity and online backup solutions.

Contact:
Greg Fanning, National Sales Director
SafeEvault
888-738-2858 opt.2
http://www.safeevault.com

See Also:

• Extraordinary Breath - Making the Power of Deep Breathing Work For You
• HealthCare.com Adds The Miami Herald to its Care Provider Search™ Network
• Motivational CDs Increase Employee & Team Productivity During Tough Economic Times
• Freescale and Monebo Launch ECG-on-a-Chip Platform Solution to Aid Heart Monitoring : Advanced Hardware and Software Technology Designed to Enable More Efficient and Higher Quality Cardiac Care
• Can you ‘report freely’ with some Olympic internet restrictions?

[Via PRWeb: Medical Dental]